• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰银屑病的流行病学:患病率、发病率和死亡率

Epidemiology of Psoriasis in Poland: Prevalence, Incidence, and Mortality Rates.

作者信息

Bartosińska Joanna, Szepietowski Jacek C, Raczkiewicz Dorota, Griffiths Christopher E M, Ashcroft Darren M, Wright Alison K, Podwójcic Krzysztof, Turcza Jakub, Maluchnik Michał, Chłoń-Domińczak Agnieszka, Krasowska Dorota

机构信息

Department of Dermatology, Venereology and Pediatric Dermatology, Medical University of Lublin, Lublin, Poland.

Department of Cosmetology and Aesthetic Medicine, Medical University of Lublin, Lublin, Poland.

出版信息

Int J Dermatol. 2025 Sep;64(9):1599-1606. doi: 10.1111/ijd.17848. Epub 2025 May 19.

DOI:10.1111/ijd.17848
PMID:40390157
Abstract

BACKGROUND

Although the data on psoriasis epidemiology included in the Global Psoriasis Atlas (GPA) provide valuable information on psoriasis prevalence worldwide, the GPA database is still incomplete. Therefore, the aim of the study was to assess the prevalence, incidence, and mortality rates of psoriasis and its types in Poland based on the data registered by the National Health Fund (NHF).

METHODS

The study included psoriasis patients registered at least twice in the Polish NHF database between 2010 and 2023.

RESULTS

At the end of 2023, 639,662 living psoriasis patients had been registered in the Polish NHF database, which constituted 1.70% of the Polish general population. The percentage of female psoriasis patients was found to be higher (54.95%) than male patients (45.05%). Of all the Polish NHF-registered psoriasis patients, plaque psoriasis affected 95.66%, pustular psoriasis 3.05%, psoriatic arthritis 7.20%, and guttate psoriasis 0.27%. In comparison to the general Polish population, psoriasis prevalence was observed to be lower in children (0.84%). The all-cause mortality rate among psoriasis patients was found to be higher in comparison to the general Polish population, with a higher mortality rate noted in male psoriasis patients.

CONCLUSIONS

The NHF database we studied suggests a direct relationship between the prevalence, incidence, and all-cause mortality rates in psoriasis and patients' age and sex. However, the study also revealed a decrease in mortality rates and a slow increase in the prevalence of psoriasis in the Polish population, which calls for further studies.

摘要

背景

尽管《全球银屑病地图集》(GPA)中包含的银屑病流行病学数据提供了全球银屑病患病率的宝贵信息,但GPA数据库仍不完整。因此,本研究的目的是根据国家卫生基金(NHF)登记的数据评估波兰银屑病及其各类型的患病率、发病率和死亡率。

方法

该研究纳入了2010年至2023年间在波兰NHF数据库中至少登记过两次的银屑病患者。

结果

截至2023年底,波兰NHF数据库中登记了639,662名在世的银屑病患者,占波兰总人口的1.70%。发现女性银屑病患者的比例(54.95%)高于男性患者(45.05%)。在所有波兰NHF登记的银屑病患者中,斑块状银屑病患者占95.66%,脓疱型银屑病患者占3.05%,银屑病关节炎患者占7.20%,点滴状银屑病患者占0.27%。与波兰普通人群相比,儿童中的银屑病患病率较低(0.84%)。银屑病患者的全因死亡率高于波兰普通人群,男性银屑病患者的死亡率更高。

结论

我们研究的NHF数据库表明,银屑病的患病率、发病率和全因死亡率与患者的年龄和性别之间存在直接关系。然而,该研究还揭示了波兰人群中银屑病死亡率的下降和患病率的缓慢上升,这需要进一步研究。

相似文献

1
Epidemiology of Psoriasis in Poland: Prevalence, Incidence, and Mortality Rates.波兰银屑病的流行病学:患病率、发病率和死亡率
Int J Dermatol. 2025 Sep;64(9):1599-1606. doi: 10.1111/ijd.17848. Epub 2025 May 19.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
6
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2025 Aug 6;8(8):CD011535. doi: 10.1002/14651858.CD011535.pub7.
8
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
9
Increasing Trends of Pediatric Thoracic and Lumbar Spine Fractures in the United States from 2004 to 2023: A 20-year National Injury Review Depicting Shifts in Mechanisms of Injury.2004年至2023年美国儿童胸腰椎骨折的增长趋势:一项为期20年的全国性损伤回顾,描绘损伤机制的变化
Clin Orthop Relat Res. 2025 Feb 25. doi: 10.1097/CORR.0000000000003421.
10
Anti-TNF agents for paediatric psoriasis.用于儿童银屑病的抗TNF药物。
Cochrane Database Syst Rev. 2015 Nov 24;2015(11):CD010017. doi: 10.1002/14651858.CD010017.pub2.

本文引用的文献

1
Incidence, Prevalence, and Mortality of People with Psoriasis and Psoriatic Arthritis in Taiwan: A Nationwide Cohort Study.台湾地区银屑病和银屑病关节炎患者的发病率、患病率和死亡率:一项全国性队列研究。
Acta Derm Venereol. 2022 Nov 1;102:adv00807. doi: 10.2340/actadv.v102.1962.
2
The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study.银屑病的全球、区域和国家负担:2019年全球疾病负担研究的结果与见解。
Front Med (Lausanne). 2021 Dec 16;8:743180. doi: 10.3389/fmed.2021.743180. eCollection 2021.
3
Trends in psoriatic arthritis epidemiology in Poland.
波兰银屑病关节炎流行病学趋势。
Rheumatol Int. 2021 Jan;41(1):139-145. doi: 10.1007/s00296-020-04734-x. Epub 2020 Oct 28.
4
History of global burden of disease assessment at the World Health Organization.世界卫生组织全球疾病负担评估的历史。
Arch Public Health. 2020 Aug 24;78:77. doi: 10.1186/s13690-020-00458-3. eCollection 2020.
5
National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study.银屑病的国家、地区和全球流行病学:系统分析和建模研究。
BMJ. 2020 May 28;369:m1590. doi: 10.1136/bmj.m1590.
6
Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender.一项系统性综述,研究银屑病的发病率和患病率随时间的变化以及按年龄和性别划分的差异。
Br J Dermatol. 2021 Feb;184(2):243-258. doi: 10.1111/bjd.19169. Epub 2020 Jun 21.
7
All-cause and cause-specific mortality in psoriasis: A systematic review and meta-analysis.银屑病的全因和病因特异性死亡率:系统评价和荟萃分析。
J Am Acad Dermatol. 2019 May;80(5):1332-1343. doi: 10.1016/j.jaad.2018.12.037. Epub 2018 Dec 24.
8
The global state of psoriasis disease epidemiology: a workshop report.银屑病疾病流行病学的全球状况:一份研讨会报告。
Br J Dermatol. 2017 Jul;177(1):e4-e7. doi: 10.1111/bjd.15610. Epub 2017 May 28.
9
Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study.银屑病患者的发病率、患病率及死亡率:一项基于英国人群的队列研究。
Br J Dermatol. 2017 Mar;176(3):650-658. doi: 10.1111/bjd.15021. Epub 2016 Dec 22.
10
A systematic review of worldwide epidemiology of psoriasis.银屑病全球流行病学的系统评价。
J Eur Acad Dermatol Venereol. 2017 Feb;31(2):205-212. doi: 10.1111/jdv.13854. Epub 2016 Aug 30.